|
Status |
Public on Apr 06, 2017 |
Title |
Assessing the mechanism of action of BTK inhibitor, G7744 |
Organism |
Mus musculus |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
Purpose: to investigate the method of action (MOA) of BTK small molecule inhibitor, G7744, in a pre-clinical mouse lupus model (NZB/W F1). Hypothesis: BTK inhibition will affect B cell and myeloid cell pathways.
|
|
|
Overall design |
There are 5 mice per group. Sample groups: G1: Naive G2: Ad5 IFNa TD day 21 G3: Vehicle HPMC in citrate G4: BTK SMI G7744 100 mg/kg G5: SYK SMI G955 60 mg/kg G6: Anti ragweed IgG2a G7: mBR3 IgG2a G8: Cytoxan. Animals treated for 4 weeks. Samples: Spleen and kidney RNA from groups G1-G8.
|
|
|
Contributor(s) |
Townsend M, Ramamoorthi N, Hackney J |
Citation(s) |
28405610 |
Submission date |
Aug 26, 2015 |
Last update date |
May 15, 2019 |
Contact name |
Mark McCreary |
E-mail(s) |
mccrearm@gene.com
|
Phone |
6502254332
|
Organization name |
Genentech
|
Department |
Bioinformatics
|
Street address |
1 DNA Way, MS 93
|
City |
South San Francisco |
State/province |
California |
ZIP/Postal code |
94080 |
Country |
USA |
|
|
Platforms (1) |
GPL9185 |
Illumina Genome Analyzer (Mus musculus) |
|
Samples (114)
|
|
Relations |
BioProject |
PRJNA293990 |
SRA |
SRP062874 |